{"id": "Sw0mYdUAAAAJ", "citedby": 22118, "citedby5y": 5299, "hindex": 76, "hindex5y": 39, "i10index": 183, "i10index5y": 104, "coauthors": [], "name": "Suzanne A Fuqua", "affiliation": "Unknown affiliation", "interests": ["breast cancer"], "cites_per_year": {"1991": 103, "1992": 184, "1993": 248, "1994": 334, "1995": 513, "1996": 548, "1997": 652, "1998": 615, "1999": 581, "2000": 651, "2001": 588, "2002": 769, "2003": 701, "2004": 859, "2005": 881, "2006": 879, "2007": 837, "2008": 894, "2009": 809, "2010": 928, "2011": 896, "2012": 1005, "2013": 1056, "2014": 991, "2015": 948, "2016": 1060, "2017": 934, "2018": 964, "2019": 995, "2020": 388}, "publications": [{"bib": {"title": "Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer", "year": "2003"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:u5HHmVD_uO8C", "citedby": "909"}, {"bib": {"title": "Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer", "year": "1993"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:u-x6o8ySG0sC", "citedby": "882"}, {"bib": {"title": "Biological and clinical implications of heat shock protein 27000 (Hsp27): a review", "year": "1993"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:d1gkVwhDpl0C", "citedby": "632"}, {"bib": {"title": "International union of pharmacology. LXIV. Estrogen receptors", "year": "2006"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:qjMakFHDy7sC", "citedby": "610"}, {"bib": {"title": "HER-2/neu amplification predicts poor survival in node-positive breast cancer", "year": "1990"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:9yKSN-GCB0IC", "citedby": "601"}, {"bib": {"title": "Variant human breast tumor estrogen receptor with constitutive transcriptional activity", "year": "1991"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:2osOgNQ5qMEC", "citedby": "502"}, {"bib": {"title": "Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer", "year": "2015"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:xtRiw3GOFMkC", "citedby": "473"}, {"bib": {"title": "Histological and biological evolution of human premalignant breast disease.", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:IjCSPb-OGe4C", "citedby": "466"}, {"bib": {"title": "Estrogen receptor mutations in human disease", "year": "2004"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:zYLM7Y9cAGgC", "citedby": "463"}, {"bib": {"title": "Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications", "year": "1993"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:Tyk-4Ss8FVUC", "citedby": "458"}, {"bib": {"title": "Selective estrogen receptor modulators: structure, function, and clinical use", "year": "2000"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:UeHWp8X0CEIC", "citedby": "453"}, {"bib": {"title": "Direct acetylation of the estrogen receptor \u03b1 hinge region by p300 regulates transactivation and hormone sensitivity", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:YsMSGLbcyi4C", "citedby": "396"}, {"bib": {"title": "Estrogen receptor and breast cancer", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:_FxGoFyzp5QC", "citedby": "379"}, {"bib": {"title": "Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci", "year": "1998"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:Y0pCki6q_DkC", "citedby": "377"}, {"bib": {"title": "Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer.", "year": "1995"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:W7OEmFMy1HYC", "citedby": "351"}, {"bib": {"title": "Response of human breast cancer cells to heat shock and chemotherapeutic drugs", "year": "1992"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:WF5omc3nYNoC", "citedby": "345"}, {"bib": {"title": "Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors", "year": "1992"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:eQOLeE2rZwMC", "citedby": "325"}, {"bib": {"title": "A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:7BrZ7Jt4UNcC", "citedby": "303"}, {"bib": {"title": "MINIREVIEW: Estrogen Receptor Variants in Clinical Breast Cancer", "year": "1991"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:ufrVoPGSRksC", "citedby": "303"}, {"bib": {"title": "The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines", "year": "1993"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:roLk4NBRz8UC", "citedby": "298"}, {"bib": {"title": "A hypersensitive estrogen receptor-\u03b1 mutation in premalignant breast lesions", "year": "2000"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:UebtZRa9Y70C", "citedby": "288"}, {"bib": {"title": "The SH2 domain protein GRB\u20107 is co\u2010amplified, overexpressed and in a tight complex with HER2 in breast cancer.", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:LkGwnXOMwfcC", "citedby": "288"}, {"bib": {"title": "An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer", "year": "1997"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:KlAtU1dfN6UC", "citedby": "283"}, {"bib": {"title": "Insulin-like growth factor-ll (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor", "year": "1989"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:Se3iqnhoufwC", "citedby": "279"}, {"bib": {"title": "Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo", "year": "2000"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:8k81kl-MbHgC", "citedby": "248"}, {"bib": {"title": "Statistical analysis of array expression data as applied to the problem of tamoxifen resistance", "year": "1999"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:hqOjcs7Dif8C", "citedby": "238"}, {"bib": {"title": "Expression of wild-type estrogen receptor \u03b2 and variant isoforms in human breast cancer", "year": "1999"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:0EnyYjriUFMC", "citedby": "233"}, {"bib": {"title": "Low levels of estrogen receptor \u03b2 protein predict resistance to tamoxifen therapy in breast cancer", "year": "2004"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:MXK_kJrjxJIC", "citedby": "231"}, {"bib": {"title": "Measurement of steroid hormone receptors in breast cancer patients on tamoxifen", "year": "1993"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:5nxA0vEk-isC", "citedby": "230"}, {"bib": {"title": "Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates", "year": "2004"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:ULOm3_A8WrAC", "citedby": "223"}, {"bib": {"title": "Estrogen receptor \u03b2 protein in human breast cancer: correlation with clinical tumor parameters", "year": "2003"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:kNdYIx-mwKoC", "citedby": "218"}, {"bib": {"title": "Estrogen receptor: current understanding of its activation and modulation", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:YOwf2qJgpHMC", "citedby": "206"}, {"bib": {"title": "Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism", "year": "1989"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:3fE2CSJIrl8C", "citedby": "202"}, {"bib": {"title": "MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal \u2026", "year": "1997"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:M3ejUd6NZC8C", "citedby": "198"}, {"bib": {"title": "Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function", "year": "2002"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:Zph67rFs4hoC", "citedby": "194"}, {"bib": {"title": "Expression of a constitutively active estrogen receptor variant in the estrogen receptor-negative BT-20 human breast cancer cell line", "year": "1993"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:4TOpqqG69KYC", "citedby": "173"}, {"bib": {"title": "RNA sequencing of cancer reveals novel splicing alterations", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:hMod-77fHWUC", "citedby": "167"}, {"bib": {"title": "Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:_kc_bZDykSQC", "citedby": "164"}, {"bib": {"title": "Phosphorylation of estrogen receptor \u03b1 blocks its acetylation and regulates estrogen sensitivity", "year": "2004"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:qxL8FJ1GzNcC", "citedby": "163"}, {"bib": {"title": "Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells", "year": "2010"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:ns9cj8rnVeAC", "citedby": "159"}, {"bib": {"title": "Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer", "year": "2011"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:hC7cP41nSMkC", "citedby": "157"}, {"bib": {"title": "Mechanisms of tamoxifen resistance", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:4DMP91E08xMC", "citedby": "148"}, {"bib": {"title": "Quercetin inhibits heat shock protein induction but not heat shock factor DNA-binding in human breast carcinoma cells", "year": "1997"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:7PzlFSSx8tAC", "citedby": "141"}, {"bib": {"title": "The small heat shock protein hsp27 increases invasiveness but decreases motility of breast cancer cells.", "year": "1997"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:Wp0gIr-vW9MC", "citedby": "140"}, {"bib": {"title": "Estrogen receptor mutations and changes in downstream gene expression and signaling", "year": "2010"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:HDshCWvjkbEC", "citedby": "139"}, {"bib": {"title": "G protein-coupled receptor 30 expression is up-regulated by EGF and TGF\u03b1 in estrogen receptor \u03b1-positive cancer cells", "year": "2009"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:R3hNpaxXUhUC", "citedby": "139"}, {"bib": {"title": "Estrogen receptor (ER) \u03b1 mutations in breast cancer: hidden in plain sight", "year": "2014"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:WbkHhVStYXYC", "citedby": "138"}, {"bib": {"title": "p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:dhFuZR0502QC", "citedby": "138"}, {"bib": {"title": "Molecular genetic studies of early breast cancer evolution", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:aqlVkmm33-oC", "citedby": "136"}, {"bib": {"title": "Prognostic significance of p53 gene alterations in node-negative breast cancer", "year": "1993"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:QIV2ME_5wuYC", "citedby": "132"}, {"bib": {"title": "Estrogen receptor mutations in breast cancer", "year": "1993"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:9ZlFYXVOiuMC", "citedby": "131"}, {"bib": {"title": "BRCA1 regulates acetylation and ubiquitination of estrogen receptor-\u03b1", "year": "2010"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:_Qo2XoVZTnwC", "citedby": "129"}, {"bib": {"title": "Hsp27 overexpression inhibits doxorubicin\u2013induced apoptosis in human breast cancer cells", "year": "1999"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:qUcmZB5y_30C", "citedby": "129"}, {"bib": {"title": "Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation", "year": "2000"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:ZeXyd9-uunAC", "citedby": "128"}, {"bib": {"title": "Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis", "year": "1991"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:L8Ckcad2t8MC", "citedby": "127"}, {"bib": {"title": "Induction of the estrogen-regulated \u201c24K\u201d protein by heat shock", "year": "1989"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:IWHjjKOFINEC", "citedby": "121"}, {"bib": {"title": "Heat shock proteins and drug resistance", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:-f6ydRqryjwC", "citedby": "119"}, {"bib": {"title": "Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance", "year": "2006"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:TQgYirikUcIC", "citedby": "113"}, {"bib": {"title": "Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification.", "year": "1989"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:hFOr9nPyWt4C", "citedby": "113"}, {"bib": {"title": "Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cells", "year": "1997"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:mB3voiENLucC", "citedby": "111"}, {"bib": {"title": "Leptin mediates tumor\u2013stromal interactions that promote the invasive growth of breast cancer cells", "year": "2012"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:35N4QoGY0k4C", "citedby": "99"}, {"bib": {"title": "Estrogen and progesterone receptors", "year": "2000"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:mVmsd5A6BfQC", "citedby": "98"}, {"bib": {"title": "Metastasis-associated protein 2 is a repressor of estrogen receptor \u03b1 whose overexpression leads to estrogen-independent growth of human breast cancer cells", "year": "2006"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:r0BpntZqJG4C", "citedby": "93"}, {"bib": {"title": "Abnormal estrogen receptor in clinical breast cancer", "year": "1992"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:e5wmG9Sq2KIC", "citedby": "93"}, {"bib": {"title": "The role of estrogen receptors in breast cancer metastasis", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:TFP_iSt0sucC", "citedby": "91"}, {"bib": {"title": "Molecular aspects of estrogen receptor variants in breast cancer", "year": "1995"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:iH-uZ7U-co4C", "citedby": "91"}, {"bib": {"title": "Auto-regulation of the estrogen receptor promoter", "year": "1997"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:k_IJM867U9cC", "citedby": "90"}, {"bib": {"title": "Estrogen receptors in breast cancer therapy", "year": "1996"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:isC4tDSrTZIC", "citedby": "88"}, {"bib": {"title": "An exon 5 deletion variant of the estrogen receptor frequently coexpressed with wild-type estrogen receptor in human breast cancer", "year": "1993"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:RHpTSmoSYBkC", "citedby": "88"}, {"bib": {"title": "Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression", "year": "2012"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:4OULZ7Gr8RgC", "citedby": "87"}, {"bib": {"title": "Multiple splicing variants of the estrogen receptor are present in individual human breast tumors", "year": "1996"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:4JMBOYKVnBMC", "citedby": "85"}, {"bib": {"title": "P-glycoprotein expression in human breast cancer cells", "year": "1987"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:M3NEmzRMIkIC", "citedby": "84"}, {"bib": {"title": "AR collaborates with ER\u03b1 in aromatase inhibitor-resistant breast cancer", "year": "2014"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:t6usbXjVLHcC", "citedby": "82"}, {"bib": {"title": "Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer.", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:bEWYMUwI8FkC", "citedby": "82"}, {"bib": {"title": "Sensitive detection of estrogen receptor RNA by polymerase chain reaction assay", "year": "1990"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:j3f4tGmQtD8C", "citedby": "79"}, {"bib": {"title": "Transcriptomic landscape of breast cancers through mRNA sequencing", "year": "2012"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:abG-DnoFyZgC", "citedby": "77"}, {"bib": {"title": "Tamoxifen resistance in breast cancer", "year": "1993"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:BqipwSGYUEgC", "citedby": "76"}, {"bib": {"title": "Tumor suppressor genes in breast cancer.", "year": "1999"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:lSLTfruPkqcC", "citedby": "74"}, {"bib": {"title": "Estrogen receptor variants", "year": "1998"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:blknAaTinKkC", "citedby": "74"}, {"bib": {"title": "The role and prognostic significance of p53 gene alterations in breast cancer", "year": "1993"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:YFjsv_pBGBYC", "citedby": "74"}, {"bib": {"title": "Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor \u03b1 gene expression via p38MAPK/CK2 signaling in human breast \u2026", "year": "2011"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:g5m5HwL7SMYC", "citedby": "72"}, {"bib": {"title": "Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth", "year": "2014"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:sSrBHYA8nusC", "citedby": "71"}, {"bib": {"title": "The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients.", "year": "1996"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:JV2RwH3_ST0C", "citedby": "71"}, {"bib": {"title": "Genomic approaches in the management and treatment of breast cancer", "year": "2005"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:GnPB-g6toBAC", "citedby": "70"}, {"bib": {"title": "The role of the estrogen receptor in tumor progression", "year": "1996"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:RGFaLdJalmkC", "citedby": "70"}, {"bib": {"title": "A simple polymerase chain reaction method for detection and cloning of low-abundance transcripts.", "year": "1990"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:NMxIlDl6LWMC", "citedby": "70"}, {"bib": {"title": "Immunohistochemical studies of early breast cancer evolution", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:maZDTaKrznsC", "citedby": "68"}, {"bib": {"title": "Combined low doses of PPAR\u03b3 and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells", "year": "2009"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:70eg2SAEIzsC", "citedby": "67"}, {"bib": {"title": "Expression of the K303R estrogen receptor-\u03b1 breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway", "year": "2009"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:zA6iFVUQeVQC", "citedby": "66"}, {"bib": {"title": "Negative regulation of estrogen receptor \u03b1 transactivation functions by LIM domain only 4 protein", "year": "2005"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:J_g5lzvAfSwC", "citedby": "66"}, {"bib": {"title": "Targeted therapy for breast cancer and molecular mechanisms of resistance to treatment", "year": "2016"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:4X0JR2_MtJMC", "citedby": "65"}, {"bib": {"title": "Estrogen receptor \u03b1\u2013negative breast cancer tissues express significant levels of estrogen-independent transcription factors, ER\u03b21 and ER\u03b25: potential molecular targets for \u2026", "year": "2005"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:vV6vV6tmYwMC", "citedby": "60"}, {"bib": {"title": "Biomarkers in early breast neoplasia", "year": "1993"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:O3NaXMp0MMsC", "citedby": "60"}, {"bib": {"title": "Tamoxifen regulates cell fate through mitochondrial estrogen receptor beta in breast cancer", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:NhqRSupF_l8C", "citedby": "59"}, {"bib": {"title": "Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor\u2013positive human breast cancer cells", "year": "2006"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:NaGl4SEjCO4C", "citedby": "59"}, {"bib": {"title": "Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:b0M2c_1WBrUC", "citedby": "58"}, {"bib": {"title": "Association between the estrogen receptor \u03b1 A908G mutation and outcomes in invasive breast cancer", "year": "2007"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:yD5IFk8b50cC", "citedby": "55"}, {"bib": {"title": "Evidence for diversity in transcriptional profiles of single hematopoietic stem cells", "year": "2006"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:HoB7MX3m0LUC", "citedby": "54"}, {"bib": {"title": "Estrogen receptors in resistance to hormone therapy", "year": "2007"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:a0OBvERweLwC", "citedby": "53"}, {"bib": {"title": "10 The oestrogen receptor", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:pqnbT2bcN3wC", "citedby": "53"}, {"bib": {"title": "Estrogen receptor gene methylation in human breast tumors", "year": "1990"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:2P1L_qKh6hAC", "citedby": "53"}, {"bib": {"title": "Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor \u03b1 and its phosphorylation at serine 305", "year": "2010"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:SeFeTyx0c_EC", "citedby": "52"}, {"bib": {"title": "Differential expression of wild-type and variant ER mRNAs by stocks of MCF-7 breast cancer cells may account for differences in estrogen responsiveness", "year": "1995"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:RYcK_YlVTxYC", "citedby": "52"}, {"bib": {"title": "Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression", "year": "2011"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:uWQEDVKXjbEC", "citedby": "51"}, {"bib": {"title": "Insights into the role of progesterone receptors in breast cancer", "year": "2005"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:nb7KW1ujOQ8C", "citedby": "51"}, {"bib": {"title": "Basal regulatory promoter elements of the hsp27 gene in human breast cancer cells", "year": "1996"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:rO6llkc54NcC", "citedby": "51"}, {"bib": {"title": "Phosphorylation of the mutant K303R estrogen receptor \u03b1 at serine 305 affects aromatase inhibitor sensitivity", "year": "2010"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:EUQCXRtRnyEC", "citedby": "50"}, {"bib": {"title": "Dicer-mediated upregulation of BCRP confers tamoxifen resistance in human breast cancer cells", "year": "2011"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:OU6Ihb5iCvQC", "citedby": "48"}, {"bib": {"title": "Loss of Rho GDI\u03b1 and resistance to tamoxifen via effects on estrogen receptor \u03b1", "year": "2011"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:fPk4N6BV_jEC", "citedby": "48"}, {"bib": {"title": "Sp1 is essential for estrogen receptor \u03b1 gene transcription", "year": "2002"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:M05iB0D1s5AC", "citedby": "48"}, {"bib": {"title": "A point mutation in the human estrogen receptor gene is associated with the expression of an abnormal estrogen receptor mRNA containing a 69 novel nucleotide insertion", "year": "1997"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:ldfaerwXgEUC", "citedby": "47"}, {"bib": {"title": "Novel insights into breast cancer genetic variance through RNA sequencing", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:08ZZubdj9fEC", "citedby": "46"}, {"bib": {"title": "Phosphatase PTP4A3 promotes triple-negative breast cancer growth and predicts poor patient survival", "year": "2016"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:GFxP56DSvIMC", "citedby": "45"}, {"bib": {"title": "Regulation of the estrogen receptor \u03b1 minimal promoter by Sp1, USF-1 and ER\u03b1", "year": "2004"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:cFHS6HbyZ2cC", "citedby": "44"}, {"bib": {"title": "The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain", "year": "1993"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:ZHo1McVdvXMC", "citedby": "44"}, {"bib": {"title": "Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ER\u03b1-positive breast cancer", "year": "2015"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:cWzG1nlazyYC", "citedby": "43"}, {"bib": {"title": "In vitro mechanism for downregulation of ER\u2010\u03b1 expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:geHnlv5EZngC", "citedby": "43"}, {"bib": {"title": "Expression of estrogen receptor variants", "year": "1993"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:u_35RYKgDlwC", "citedby": "43"}, {"bib": {"title": "Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer.", "year": "1995"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:dfsIfKJdRG4C", "citedby": "42"}, {"bib": {"title": "Estrogen receptor mutagenesis and hormone resistance", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:pyW8ca7W8N0C", "citedby": "42"}, {"bib": {"title": "Role of BRCA1 in heat shock response", "year": "2003"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:f2IySw72cVMC", "citedby": "41"}, {"bib": {"title": "Cyclin D1 in breast premalignancy and early breast cancer: implications for prevention and treatment", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:3s1wT3WcHBgC", "citedby": "41"}, {"bib": {"title": "Role of MTA2 in human cancer", "year": "2014"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:VL0QpB8kHFEC", "citedby": "40"}, {"bib": {"title": "Lactoferrin\u2013endothelin-1 axis contributes to the development and invasiveness of triple-negative breast cancer phenotypes", "year": "2011"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:K3LRdlH-MEoC", "citedby": "39"}, {"bib": {"title": "ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling", "year": "2016"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:lvd772isFD0C", "citedby": "38"}, {"bib": {"title": "Estrogen and progesterone receptor isoforms: clinical significance in breast cancer", "year": "2004"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:UxriW0iASnsC", "citedby": "38"}, {"bib": {"title": "Identification of genes expressed in the rat prostate that are modulated differently by castration and Finasteride treatment", "year": "1998"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:1Ye0OR6EYb4C", "citedby": "38"}, {"bib": {"title": "Chromosomal assignments of human 27-kDa heat shock protein gene family", "year": "1989"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:1sJd4Hv_s6UC", "citedby": "38"}, {"bib": {"title": "Coexpression of wild-type and variant oestrogen receptor mRNAs in a panel of human breast cancer cell lines", "year": "1995"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:_xSYboBqXhAC", "citedby": "37"}, {"bib": {"title": "A role for estrogen-receptor variants in endocrine resistance", "year": "1995"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:D03iK_w7-QYC", "citedby": "37"}, {"bib": {"title": "Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancer", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:olpn-zPbct0C", "citedby": "36"}, {"bib": {"title": "The role of androgen receptor in breast cancer", "year": "2012"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:tzM49s52ZIMC", "citedby": "36"}, {"bib": {"title": "Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor \u03b1 gene promoter", "year": "2009"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:XiSMed-E-HIC", "citedby": "36"}, {"bib": {"title": "Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter", "year": "2012"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:4fKUyHm3Qg0C", "citedby": "35"}, {"bib": {"title": "Loss of heterozygosity at D14S62 and metastatic potential of breast cancer", "year": "1999"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:bFI3QPDXJZMC", "citedby": "35"}, {"bib": {"title": "Macrophages promote the progression of premalignant mammary lesions to invasive cancer", "year": "2017"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:jL-93Qbq4QoC", "citedby": "33"}, {"bib": {"title": "A cDNA for the estradiol-regulated 24K protein: control of mRNA levels in MCF-7 cells", "year": "1988"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:CHSYGLWDkRkC", "citedby": "33"}, {"bib": {"title": "Mechanisms of action of antiestrogens", "year": "1995"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:SP6oXDckpogC", "citedby": "31"}, {"bib": {"title": "A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer", "year": "2011"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:8AbLer7MMksC", "citedby": "30"}, {"bib": {"title": "The c-Yes 3\u2032-UTR contains adenine/uridine-rich elements that bind AUF1 and HuR involved in mRNA decay in breast cancer cells", "year": "2005"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:p2g8aNsByqUC", "citedby": "30"}, {"bib": {"title": "The p53 tumor-suppressor gene in human breast cancer", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:KxtntwgDAa4C", "citedby": "30"}, {"bib": {"title": "The promise of microarrays in the management and treatment of breast cancer", "year": "2005"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:u9iWguZQMMsC", "citedby": "29"}, {"bib": {"title": "Secreted growth factors from estrogen receptor-negative human breast cancer do not support growth of estrogen receptor-positive breast cancer in the nude mouse model", "year": "1988"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:P5F9QuxV20EC", "citedby": "29"}, {"bib": {"title": "Hsp27-induced MMP-9 expression is influenced by the Src tyrosine protein kinase yes", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:dshw04ExmUIC", "citedby": "28"}, {"bib": {"title": "Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing \u2026", "year": "2018"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:ubry08Y2EpUC", "citedby": "26"}, {"bib": {"title": "Targeting thyroid hormone receptor beta in triple-negative breast cancer", "year": "2015"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:uJ-U7cs_P_0C", "citedby": "26"}, {"bib": {"title": "Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival", "year": "2018"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:owLR8QvbtFgC", "citedby": "25"}, {"bib": {"title": "A hypersensitive estrogen receptor \u03b1 mutation that alters dynamic protein interactions", "year": "2010"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:LPZeul_q3PIC", "citedby": "23"}, {"bib": {"title": "Glutathione transferase GST\u03c0 in breast tumors evaluated by three techniques", "year": "1993"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:738O_yMBCRsC", "citedby": "23"}, {"bib": {"title": "Alterations in the estrogen receptor alpha mRNA in the breast tumors of African American women", "year": "2000"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:Tiz5es2fbqcC", "citedby": "22"}, {"bib": {"title": "Heat shock/stress response proteins and prognosis in cancer", "year": "1995"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:tOudhMTPpwUC", "citedby": "22"}, {"bib": {"title": "Constitutive overexpression of the 27,000 dalton heat shock protein in late passage human breast cancer cells", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:vRqMK49ujn8C", "citedby": "22"}, {"bib": {"title": "The importance of the estrogen receptor in breast cancer", "year": "2002"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:uDGL6kOW6j0C", "citedby": "21"}, {"bib": {"title": "Inhibition of mammary tumorigenesis by estrogen and progesterone in genetically engineered mice", "year": "2008"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:eJXPG6dFmWUC", "citedby": "20"}, {"bib": {"title": "Alterations within the estrogen receptor in breast cancer", "year": "1996"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:tS2w5q8j5-wC", "citedby": "20"}, {"bib": {"title": "PIK3CA mutations and/or low PTEN predict resistance to combined anti-HER2 therapy with lapatinib and trastuzumab and without chemotherapy in TBCRC006, a neoadjuvant trial of \u2026", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:NDuN12AVoxsC", "citedby": "19"}, {"bib": {"title": "Progesterone receptor gene restriction fragment length polymorphisms in human breast tumors", "year": "1991"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:l7t_Zn2s7bgC", "citedby": "19"}, {"bib": {"title": "Proteomic profiling identifies key coactivators utilized by mutant ER\u03b1 proteins as potential new therapeutic targets", "year": "2018"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:CB2v5VPnA5kC", "citedby": "18"}, {"bib": {"title": "S1-5: Modulation of Cancer and Stem Cell Biomarkers by the Notch Inhibitor MK-0752 Added to Endocrine Therapy for Early Stage ER+ Breast Cancer.", "year": "2011"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:VOx2b1Wkg3QC", "citedby": "18"}, {"bib": {"title": "Methods and compositions for detection, diagnosis and prediction of antiestrogen-resistant breast cancer", "year": "2002"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:wbdj-CoPYUoC", "citedby": "18"}, {"bib": {"title": "RNA expression profile predicting response to tamoxifen in breast cancer patients", "year": "2006"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:xtoqd-5pKcoC", "citedby": "17"}, {"bib": {"title": "Isolation and characterization of an adriamycin-resistant breast tumor cell line", "year": "1990"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:5Ul4iDaHHb8C", "citedby": "17"}, {"bib": {"title": "Mutations in the estrogen receptor alpha hormone binding domain promote stem cell phenotype through notch activation in breast cancer cell lines", "year": "2018"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:7H_MAutzIkAC", "citedby": "16"}, {"bib": {"title": "Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis", "year": "2017"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:wMgC3FpKEyYC", "citedby": "15"}, {"bib": {"title": "ESR1 mutations in breast cancer: proof-of-concept challenges clinical action", "year": "2016"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:hMsQuOkrut0C", "citedby": "15"}, {"bib": {"title": "The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer", "year": "2018"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:PYBJJbyH-FwC", "citedby": "14"}, {"bib": {"title": "Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion", "year": "2016"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:vDZJ-YLwNdEC", "citedby": "14"}, {"bib": {"title": "Induction of heat shock protein 27 by hydroxyurea and its relationship to experimental metastasis", "year": "1998"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:eflP2zaiRacC", "citedby": "14"}, {"bib": {"title": "Estrogen receptor variants in breast cancer", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:fQNAKQ3IYiAC", "citedby": "13"}, {"bib": {"title": "The importance of normal and abnormal oestrogen receptor in breast cancer.", "year": "1992"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:q3oQSFYPqjQC", "citedby": "13"}, {"bib": {"title": "P-glycoprotein gene amplification or overexpression is not detected in clinical breast cancer specimens.", "year": "1988"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:V3AGJWp-ZtQC", "citedby": "13"}, {"bib": {"title": "A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer", "year": "2019"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:-7ulzOJl1JYC", "citedby": "12"}, {"bib": {"title": "Identification of a novel estrogen receptor-\u03b1 variant and its upstream splicing regulator", "year": "2010"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:eq2jaN3J8jMC", "citedby": "12"}, {"bib": {"title": "Production and characterization of an estrogen receptor \u03b2 subtype-specific mouse monoclonal antibody", "year": "2000"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:1qzjygNMrQYC", "citedby": "12"}, {"bib": {"title": "Molecular pharmacology of estrogen and progesterone receptors", "year": "2000"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:4xDN1ZYqzskC", "citedby": "12"}, {"bib": {"title": "Pathogenesis of estrogen-receptor-positive and-negative breast cancer", "year": "2000"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:kRWSkSYxWN8C", "citedby": "12"}, {"bib": {"title": "Cell turnover (proliferation and apoptosis) in normal epithelium and premalignant lesions in the same breast.", "year": "1997"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:J-pR_7NvFogC", "citedby": "12"}, {"bib": {"title": "OVEREXPRESSION OF P53 IN NODE-POSITIVE BREAST-CANCER", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:B3FOqHPlNUQC", "citedby": "12"}, {"bib": {"title": "Where is the lesion in hormone-independent breast cancer?", "year": "1992"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:mvPsJ3kp5DgC", "citedby": "12"}, {"bib": {"title": "Methods and compositions in breast cancer diagnosis and therapeutics", "year": "2004"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:JoZmwDi-zQgC", "citedby": "11"}, {"bib": {"title": "Targeting the estrogen receptor in clinical breast cancer1", "year": "2002"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:bnK-pcrLprsC", "citedby": "11"}, {"bib": {"title": "Low cell motility induced by hsp27 overexpression decreases osteolytic bone metastases of human breast cancer cells in vivo", "year": "1999"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:XiVPGOgt02cC", "citedby": "10"}, {"bib": {"title": "INSULIN-LIKE GROWTH FACTOR-II (IGF-II)-A POTENTIAL AUTOCRINE GROWTH-FACTOR FOR HUMAN-BREAST CANCER", "year": "1988"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:D_sINldO8mEC", "citedby": "10"}, {"bib": {"title": "Clinical relevance of estrogen receptor variants in breast cancer", "year": "1995"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:5ugPr518TE4C", "citedby": "9"}, {"bib": {"title": "Abstract PD05-12: Combination of Notch Inhibitor MK-0752 and Endocrine Therapy for Early Stage ER\u03b1+ Breast Cancer in a Presurgical Window Pilot Study", "year": "2010"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:uWiczbcajpAC", "citedby": "8"}, {"bib": {"title": "Clinical syndromes of hormone receptor mutations: hormone resistance and independence", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:Mojj43d5GZwC", "citedby": "8"}, {"bib": {"title": "Abnormal oestrogen receptor in clinical breast cancer", "year": "1992"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:HE397vMXCloC", "citedby": "8"}, {"bib": {"title": "P-glycoprotein in breast cancer", "year": "1989"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:WA5NYHcadZ8C", "citedby": "8"}, {"bib": {"title": "ESR1 mutations in breast cancer", "year": "2019"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:HGTzPopzzJcC", "citedby": "7"}, {"bib": {"title": "Hormone action and clinical significance of the estrogen receptor \u03b1", "year": "2009"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:dTyEYWd-f8wC", "citedby": "7"}, {"bib": {"title": "The K303R estrogen receptor alpha breast cancer mutant generates a new Akt kinase site", "year": "2004"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:Y5dfb0dijaUC", "citedby": "6"}, {"bib": {"title": "Genomic approaches to understanding and treating breast cancer", "year": "2004"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:AXPGKjj_ei8C", "citedby": "6"}, {"bib": {"title": "Expression of Estrogen Receptor \u03b2 Protein in Human Breast Cancer: Correlation with Clinical Tumor Parameters.", "year": "2000"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:ILKRHgRFtOwC", "citedby": "6"}, {"bib": {"title": "RNA from Air-Dried Frozen Sections for RTPCR and Differential Display", "year": "1996"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:_B80troHkn4C", "citedby": "6"}, {"bib": {"title": "Abnormalities of the estrogen receptor in breast cancer\u2014introduction", "year": "1993"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:eMMeJKvmdy0C", "citedby": "6"}, {"bib": {"title": "Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort", "year": "2016"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:LgRImbQfgY4C", "citedby": "5"}, {"bib": {"title": "Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ER\u03b1 transgenic mice", "year": "2009"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:ye4kPcJQO24C", "citedby": "5"}, {"bib": {"title": "FKHR functions as a bifunctional nuclear receptor interacting protein with both coactivator and corepressor functions", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:tkaPQYYpVKoC", "citedby": "5"}, {"bib": {"title": "Selective estrogen receptor modulators. An aid in unraveling the links between estrogen and breast cancer.", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:9vf0nzSNQJEC", "citedby": "5"}, {"bib": {"title": "Methods and compositions in breast cancer diagnosis and therapeutics", "year": "2008"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:XUvXOeBm_78C", "citedby": "4"}, {"bib": {"title": "Role of altered estrogen receptors in breast cancer", "year": "1996"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:PELIpwtuRlgC", "citedby": "4"}, {"bib": {"title": "Estrogen and progesterone receptor variants in human breast cancer", "year": "1995"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:SdhP9T11ey4C", "citedby": "4"}, {"bib": {"title": "ESR1 mutations in cell-free DNA of breast cancer: predictive \u201ctip of the iceberg\u201d", "year": "2016"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:Ak0FvsSvgGUC", "citedby": "3"}, {"bib": {"title": "Phosphorylated and small ubiquitin-like modifier protein-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression", "year": "2012"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:FiytvqdAVhgC", "citedby": "3"}, {"bib": {"title": "PD01-07: AR Overexpression and Aromatase Inhibitor Resistance in Breast Cancer.", "year": "2011"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:1yQoGdGgb4wC", "citedby": "3"}, {"bib": {"title": "Pharmacogenetics of breast cancer: toward the individualization of therapy", "year": "2009"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:5awf1xo2G04C", "citedby": "3"}, {"bib": {"title": "Hormone receptors in breast cancer", "year": "2008"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:LjlpjdlvIbIC", "citedby": "3"}, {"bib": {"title": "A naturally occurring point mutation alters ER\u03b1 crosstalk with regulatory signaling pathways.", "year": "2002"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:N5tVd3kTz84C", "citedby": "3"}, {"bib": {"title": "Evaluation of thymidylate synthase RNA expression by polymerase chain reaction", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:uLbwQdceFCQC", "citedby": "3"}, {"bib": {"title": "Laboratory aspects of multidrug resistance", "year": "1989"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:WqliGbK-hY8C", "citedby": "3"}, {"bib": {"title": "The 24K estrogen-regulated protein is a heat-shock protein", "year": "1987"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:ZfRJV9d4-WMC", "citedby": "3"}, {"bib": {"title": "Abstract LB-121: DAXX is a novel Notch-1 gene target and biomarker of GSI-sensitivity in ER+ breast cancer", "year": "2016"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:Bg7qf7VwUHIC", "citedby": "2"}, {"bib": {"title": "Abstract PD1-2: PIK3CA mutations and/or low PTEN predict resistance to combined anti-HER2 therapy with lapatinib and trastuzumab and without chemotherapy in TBCRC006, a \u2026", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:BrmTIyaxlBUC", "citedby": "2"}, {"bib": {"title": "A new functional classification of lung and breast cancers based on siRNA mediated knockdown of 48 NRs and 72 CoRegulators", "year": "2012"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:bz8QjSJIRt4C", "citedby": "2"}, {"bib": {"title": "Hormone resistance", "year": "2008"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:j7_hQOaDUrUC", "citedby": "2"}, {"bib": {"title": "Methods and compositions in breast cancer diagnosis and therapeutics", "year": "2008"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:PVgj2kMGcgYC", "citedby": "2"}, {"bib": {"title": "The estrogen receptor \u03b1 A908G mutation is present in invasive breast cancer", "year": "2005"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:UHK10RUVsp4C", "citedby": "2"}, {"bib": {"title": "c-Src inhibition with AZD0530 reduces estrogen mediated growth and invasion in breast cancer cells expressing the K303R ER\u03b1 mutant.", "year": "2005"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:ZuybSZzF8UAC", "citedby": "2"}, {"bib": {"title": "CELL GROWTH AND DEVELOPMENT-Androgen Receptor Acetylation Governs trans Activation and MEKK1-Induced Apoptosis without Affecting In Vitro Sumoylation and trans-Repression Function", "year": "2002"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:jFemdcug13IC", "citedby": "2"}, {"bib": {"title": "A hypersensitive estrogen receptor \u03b1 is common in invasive breast cancer.", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:dQ2og3OwTAUC", "citedby": "2"}, {"bib": {"title": "A Hypersensitive Estrogen Receptor \u03b1 Protein in Premalignant Breast Lesions.", "year": "2000"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:hkOj_22Ku90C", "citedby": "2"}, {"bib": {"title": "The estrogen receptor and breast cancer", "year": "1999"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:PR6Y55bgFSsC", "citedby": "2"}, {"bib": {"title": "Prognostic factors and variant estrogen receptor RNAs in clinical breast cancer", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:kzcrU_BdoSEC", "citedby": "2"}, {"bib": {"title": "The Y537S ESR1 mutation is a dominant driver of distant ER-positive breast cancer metastasis", "year": "2018"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:prdVHNxh-e8C", "citedby": "1"}, {"bib": {"title": "Erratum to: ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling", "year": "2017"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:otzGkya1bYkC", "citedby": "1"}, {"bib": {"title": "Identification of the activated form of the progesterone receptor (PR) in breast cancer (BC).", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:IUKN3-7HHlwC", "citedby": "1"}, {"bib": {"title": "Collaboration of AR and ER\u03b1 in conferring resistance to an aromatase inhibitor.", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:Ri6SYOTghG4C", "citedby": "1"}, {"bib": {"title": "Independent characterization by duel staining of progesterone receptor (PR) and estrogen receptor (ER) in breast cancer (BC).", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:_Re3VWB3Y0AC", "citedby": "1"}, {"bib": {"title": "EBP50: Novel biomarker for resistance to endocrine and HER-2 targeted therapies in breast cancer..", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:gsN89kCJA0AC", "citedby": "1"}, {"bib": {"title": "MTA2 Enhances Breast Cancer Metastasis by Regulating the Rho Signaling Pathway.", "year": "2009"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:tKAzc9rXhukC", "citedby": "1"}, {"bib": {"title": "Hormone Receptors in Breast Cancer (Cancer Treatment and Research; 312)", "year": "2009"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:6_hjMsCP8ZoC", "citedby": "1"}, {"bib": {"title": "Utility of microarrays in the management of breast cancer patients", "year": "2005"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:oNZyr7d5Mn4C", "citedby": "1"}, {"bib": {"title": "The MAPK inhibitor, MKP3, is an estrogen receptor \u03b1 coactivator associated with tamoxifen resistance", "year": "2005"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:7T2F9Uy0os0C", "citedby": "1"}, {"bib": {"title": "Detection of estrogen receptor-beta and methods for diagnosis and classification of cancer", "year": "2003"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:5icHVeHT4IsC", "citedby": "1"}, {"bib": {"title": "Estrogen and progesterone receptors in breast cancer", "year": "2003"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:LdasjJ6CEcoC", "citedby": "1"}, {"bib": {"title": "Consensus statement: expedition inspiration fund for Breast Cancer Research Meeting 2002", "year": "2003"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:JQOojiI6XY0C", "citedby": "1"}, {"bib": {"title": "Genetic alterations in the progression of non-invasive to invasive breast cancer.", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:NJ774b8OgUMC", "citedby": "1"}, {"bib": {"title": "COMPARATIVE GENOMIC HYBRIDIZATION (CGH) PREDICTS RECURRENCE IN NODE-NEGATIVE BREAST-CANCER", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:W5xh706n7nkC", "citedby": "1"}, {"bib": {"title": "HEAT-SHOCK PROTEIN-27 IS ESTROGEN-REGULATED IN MCF-7 HUMAN-BREAST CANCER-CELLS", "year": "1988"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:Fu2w8maKXqMC", "citedby": "1"}, {"bib": {"title": "Leptin Signaling Contributes to Aromatase Inhibitor Resistant Breast Cancer Cell Growth and Activation of Macrophages", "year": "2020"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:mKu_rENv82IC", "citedby": "0"}, {"bib": {"title": "Abstract ES4-1: Adaptive Resistance to Hormonal Therapy", "year": "2020"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:sszUF3NjhM4C", "citedby": "0"}, {"bib": {"title": "Abstract PD7-03: Adaptive kinome reprogramming in endocrine therapy resistant metastatic breast cancer", "year": "2020"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:U_HPUtbDl20C", "citedby": "0"}, {"bib": {"title": "Estrogen-induced transcription at individual alleles is independent of receptor level and active conformation but can be modulated by coactivators activity", "year": "2020"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:-jrNzM816MMC", "citedby": "0"}, {"bib": {"title": "Novel clinical targets revealed by kinome reprogramming in mutant ESR1 metastatic breast cancer", "year": "2019"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:MAUkC_7iAq8C", "citedby": "0"}, {"bib": {"title": "Abstract PD7-11: Therapeutic strategy for ESR1 mutation driven-endocrine resistance in ER-positive breast cancers", "year": "2019"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:KaMxkj08jr0C", "citedby": "0"}, {"bib": {"title": "Abstract P4-04-08: Therapeutic strategy for ER\u03b1 mutation driven-endocrine resistance in ER-positive breast cancers", "year": "2018"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:MhiOAD_qIWkC", "citedby": "0"}, {"bib": {"title": "Abstract P1-02-03: The Y537S ESR1 mutation carries unique metabolomics profiling in breast cancer", "year": "2018"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:kw52XkFRtyQC", "citedby": "0"}, {"bib": {"title": "Genomic Alterations in the Estrogen Receptor: Implications for Treatment", "year": "2018"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:nZcligLrVowC", "citedby": "0"}, {"bib": {"title": "Abstract S4-02: The Y537S ESR1 mutation is a dominant driver of distant ER-positive breast cancer metastasis", "year": "2017"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:QD3KBmkZPeQC", "citedby": "0"}, {"bib": {"title": "Clonal evolution of the HER2 L755S mutation leads to acquired HER-targeted therapy resistance that can be reversed by the irreversible HER1/2 inhibitor afatinib", "year": "2016"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:nVrZBo8bIpAC", "citedby": "0"}, {"bib": {"title": "Erratum to: Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter", "year": "2016"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:Aul-kAQHnToC", "citedby": "0"}, {"bib": {"title": "Mechanisms of action of selective estrogen receptor modulators and down regulators", "year": "2016"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:WHdLCjDvYFkC", "citedby": "0"}, {"bib": {"title": "Clonal evolution of the HER2 L755S mutation as a mechanism of acquired HER-targeted therapy resistance", "year": "2015"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:vbGhcppDl1QC", "citedby": "0"}, {"bib": {"title": "Identification of a notch-driven breast cancer stem cell gene signature for anti-notch therapy in an ER plus presurgical window model", "year": "2015"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:Ade32sEp0pkC", "citedby": "0"}, {"bib": {"title": "Abstract PD6-6: Estrogen receptor (ESR1) mutations confer resistance to hormone therapy using a common mechanism", "year": "2015"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:IRz6iEL74y4C", "citedby": "0"}, {"bib": {"title": "Abstract S4-03: Identification of a notch-driven breast cancer stem cell gene signature for anti-notch therapy in an ER+ presurgical window model", "year": "2015"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:k8Z6L05lTy4C", "citedby": "0"}, {"bib": {"title": "Abstract P5-05-03: Clonal evolution of the HER2 L755S mutation leads to acquired HER-targeted therapy resistance that can be reversed by the irreversible HER1/2 inhibitor afatinib", "year": "2015"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:9Nmd_mFXekcC", "citedby": "0"}, {"bib": {"title": "A Selective Estrogen Receptor Beta Antagonist Reverses Tamoxifen Resistance and Augments Chemotherapy-Induced Cytotoxicity in Breast Cancer", "year": "2014"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:F9fV5C73w3QC", "citedby": "0"}, {"bib": {"title": "AR Is an ER-alpha Collaborating Factor in Hormone Resistant Breast Cancer", "year": "2014"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:0izLItjtcgwC", "citedby": "0"}, {"bib": {"title": "An innovative role of thyroid receptor \u03b2 in triple-negative breast cancer (58.4)", "year": "2014"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:HbR8gkJAVGIC", "citedby": "0"}, {"bib": {"title": "Abstract ES04-2: Understanding nuclear receptor in breast cancer", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:9c2xU6iGI7YC", "citedby": "0"}, {"bib": {"title": "Clinical and pathological correlation of the activated form of the progesterone receptor (PR) in breast cancer (BC)", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:Z5m8FVwuT1cC", "citedby": "0"}, {"bib": {"title": "Clinical and pathologic correlation of the activated form of the estrogen receptor (ER) in breast cancer (BC).", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:XvxMoLDsR5gC", "citedby": "0"}, {"bib": {"title": "Identification of the activated form of the estrogen receptor (ER) in breast cancer (BC).", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:L7CI7m0gUJcC", "citedby": "0"}, {"bib": {"title": "An RNAi-based functional classification of lung cancer reveals recurring subgroups strongly correlated with EMT status.", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:P7Ujq4OLJYoC", "citedby": "0"}, {"bib": {"title": "Phosphorylated and SUMO-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression.", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:LhH-TYMQEocC", "citedby": "0"}, {"bib": {"title": "Identification of four subgroups of Triple Negative Breast Cancer (TNBC) by genomic profiling.", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:4hFrxpcac9AC", "citedby": "0"}, {"bib": {"title": "Aromatase Inhibitor Resistance in Breast Cancer: a Potential Role for Cytokine Signaling Network.", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:URolC5Kub84C", "citedby": "0"}, {"bib": {"title": "ESTROGEN RECEPTOR VARIANTS IN BREAST", "year": "2013"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:0KyAp5RtaNEC", "citedby": "0"}, {"bib": {"title": "Abstract P4-08-09: Targeting Thyroid Receptor b in Estrogen Receptor Negative Breast Cancer", "year": "2012"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:TIZ-Mc8IlK0C", "citedby": "0"}, {"bib": {"title": "Department of Medicine/Oncology, University of Texas Health", "year": "2012"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:EkHepimYqZsC", "citedby": "0"}, {"bib": {"title": "Nuclear receptors as novel targets in ER negative breast cancer", "year": "2012"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:ipzZ9siozwsC", "citedby": "0"}, {"bib": {"title": "Estrogen Receptor-Positive Breast Cancer Cells Drive CAFs to Secrete Leptin and Support Tumor Invasiveness", "year": "2012"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:5qfkUJPXOUwC", "citedby": "0"}, {"bib": {"title": "Leptin Increases HER2 Stability through HSP90 in Breast Cancer Cells", "year": "2012"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:foquWX3nUaYC", "citedby": "0"}, {"bib": {"title": "Chronic Myeloid Leukemia-CD34+/CD38-stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicin", "year": "2012"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:AHdEip9mkN0C", "citedby": "0"}, {"bib": {"title": "P1-12-04: EBP50\u2013A Novel Biomarker for Resistance to Endocrine and HER2\u2212 Targeted Therapies in Breast Cancer.", "year": "2011"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:8d8msizDQcsC", "citedby": "0"}, {"bib": {"title": "Increased activity of the Rho family of proteins results in a tamoxifen-resistant phenotype in ER\u03b1-positive breast cancer cells", "year": "2011"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:a3BOlSfXSfwC", "citedby": "0"}, {"bib": {"title": "Identification of novel nuclear receptor targets in estrogen receptor negative breast cancer", "year": "2011"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:yMeIxYmEMEAC", "citedby": "0"}, {"bib": {"title": "AR overexpression confers resistance to an aromatase inhibitor in ER\u03b1-positive breast cancer cells", "year": "2011"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:q3CdL3IzO_QC", "citedby": "0"}, {"bib": {"title": "The K303R estrogen receptor \u03b1 mutation and hormone resistance in breast cancer", "year": "2011"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:BUYA1_V_uYcC", "citedby": "0"}, {"bib": {"title": "MTA2 enhances breast cancer metastasis via regulation of the cytoskeleton and rho signaling pathways", "year": "2011"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:vDijr-p_gm4C", "citedby": "0"}, {"bib": {"title": "First evidences that Resveratrol through p53/Sin3/HDAC1 complex phosphorylation inhibits ESR1 gene expression via p38MAPK signalling.", "year": "2011"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:tYavs44e6CUC", "citedby": "0"}, {"bib": {"title": "Abstract P5-06-02: Loss of Rho GDIa Function and Tamoxifen Resistance in ERa-Positive Breast Cancer Cells", "year": "2010"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:HtS1dXgVpQUC", "citedby": "0"}, {"bib": {"title": "Abstract P5-06-08: Role of Androgen Receptor in Metastasis and Hormone Resistance of Estrogen Receptor Positive Breast Cancer", "year": "2010"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:6ZxmRoH8BuwC", "citedby": "0"}, {"bib": {"title": "Abstract P5-06-14: Ezrin Binding Protein Ebp50 Negatively Regulates HER2 and Alters Tamoxifen Sensitivity", "year": "2010"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:PVjk1bu6vJQC", "citedby": "0"}, {"bib": {"title": "Abstract P5-06-01: MTA2 and AR Overexpression in ER-Negative Breast Cancer Cells: Roles in Invasion and Metastasis", "year": "2010"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:PoWvk5oyLR8C", "citedby": "0"}, {"bib": {"title": "Activated Farnesoid X Receptor Inhibits Growth of Tamoxifen-Resistant MCF-7 Breast Cancer Cells, through Down-Regulation of HER2 Expression.", "year": "2010"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:_FM0Bhl9EiAC", "citedby": "0"}, {"bib": {"title": "Activated Farnesoid X Receptor inhibits growth of tamoxifen-resistant breast cancer cells.", "year": "2010"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:g3aElNc5_aQC", "citedby": "0"}, {"bib": {"title": "The K303R estrogen receptor alpha mutation and resistance to hormonal therapies", "year": "2010"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:ClCfbGk0d_YC", "citedby": "0"}, {"bib": {"title": "Bergapten inducing proteasome-dependent degradation of estrogen receptor alpha overcome breast cancer tamoxifen-resistance", "year": "2010"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:RoXSNcbkSzsC", "citedby": "0"}, {"bib": {"title": "Novel mechanisms of hormone resistance in breast cancer", "year": "2010"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:AvfA0Oy_GE0C", "citedby": "0"}, {"bib": {"title": "Phosphorylation of the Mutant K303R Estrogen Receptor \u03b1 at Serine 305 Impacts Aromatase Inhibitor Sensitivity.", "year": "2009"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:IaI1MmNe2tcC", "citedby": "0"}, {"bib": {"title": "MTA2-Overexpression alters Rho pathway expression and enhances the metastatic behavior of breast cancer cells", "year": "2009"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:anf4URPfarAC", "citedby": "0"}, {"bib": {"title": "Basic science:(February 2009)", "year": "2009"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:35r97b3x0nAC", "citedby": "0"}, {"bib": {"title": "Effect of estrogen receptor-positive progenitor cells on a tamoxifen resistance phenotype in breast cancer cells", "year": "2009"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:4vMrXwiscB8C", "citedby": "0"}, {"bib": {"title": "Abstract# 4990: MTA2 overexpression enhances metastasis and alters cell adhesion in breast cancer", "year": "2009"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:MLfJN-KU85MC", "citedby": "0"}, {"bib": {"title": "Abstract# 3847: K303/S305 residues of estrogen receptor alpha: new insights in aromatase inhibitor resistance", "year": "2009"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:VLnqNzywnoUC", "citedby": "0"}, {"bib": {"title": "The K303R ER\u03b1 mutation and aromatase inhibitor resistance.", "year": "2009"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:FAceZFleit8C", "citedby": "0"}, {"bib": {"title": "MTA2 is a metastasis promoter in breast cancer cells.", "year": "2009"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:zLWjf1WUPmwC", "citedby": "0"}, {"bib": {"title": "Androgen receptor implicated in breast cancer hormone resistance", "year": "2008"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:LI9QrySNdTsC", "citedby": "0"}, {"bib": {"title": "MTA2 overexpression modulates the metastatic potential of breast cancer cells", "year": "2008"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:tuHXwOkdijsC", "citedby": "0"}, {"bib": {"title": "Pharmacogenetics of breast cancer", "year": "2008"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:tH6gc1N1XXoC", "citedby": "0"}, {"bib": {"title": "A unique model of estrogen receptor (ER) \u03b1-positive breast cancer metastasis", "year": "2007"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:bKqednn6t2AC", "citedby": "0"}, {"bib": {"title": "Mitogen activated protein kinase (MAPK) regulation of estrogen receptor (ER) \u03b1 and tamoxifen resistance", "year": "2007"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:4fGpz3EwCPoC", "citedby": "0"}, {"bib": {"title": "Tamoxifen resistance and tumor initiation mediated by Dicer overexpression in breast cancer progenitor cells-role of BCRP", "year": "2007"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:86PQX7AUzd4C", "citedby": "0"}, {"bib": {"title": "A phase II study of anastrazole and fulvestrant in combination with gefitinib in patients with newly diagnosed ER-positive breast cancer", "year": "2007"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:p__nRnzSRKYC", "citedby": "0"}, {"bib": {"title": "Ezrin binding protein Ebp50 is an intermediary of tamoxifen resistance", "year": "2006"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:HeT0ZceujKMC", "citedby": "0"}, {"bib": {"title": "Breast cancer stem cells and tamoxifen resistance", "year": "2006"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:mNrWkgRL2YcC", "citedby": "0"}, {"bib": {"title": "Role of the androgen receptor in tamoxifen resistance in breast cancer", "year": "2006"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:OTTXONDVkokC", "citedby": "0"}, {"bib": {"title": "ErbB3 is required for Src induced ligand-independent activation of ErbB2", "year": "2006"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:9pM33mqn1YgC", "citedby": "0"}, {"bib": {"title": "RhoGDI\u03b1 is an ER\u03b1 function modulator whose loss of expression is associated with tamoxifen resistance", "year": "2006"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:t7zJ5fGR-2UC", "citedby": "0"}, {"bib": {"title": "Mechanisms of Resistance to Hormone Therapy", "year": "2006"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:BwyfMAYsbu0C", "citedby": "0"}, {"bib": {"title": "Protein acetylation and hormone-independent breast cancer", "year": "2005"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:ODE9OILHJdcC", "citedby": "0"}, {"bib": {"title": "Signalling by Steroid Receptors", "year": "2005"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:1taIhTC69MYC", "citedby": "0"}, {"bib": {"title": "The Role of Estrogen Receptor a K303R Mutation in Breast Cancer Metastasis", "year": "2004"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:6yz0xqPARnAC", "citedby": "0"}, {"bib": {"title": "The Role of Estrogen Receptor a K303R Mutation in Breast Cancer Metastasis", "year": "2004"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:OP4eGU-M3BUC", "citedby": "0"}, {"bib": {"title": "Prognostic Value of the K303R Estrogen Receptor Alpha Mutation in Breast Cancer", "year": "2004"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:3htObqc8RwsC", "citedby": "0"}, {"bib": {"title": "Increased steady state levels of the K303R estrogen receptor \u03b1 mutant", "year": "2004"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:yB1At4FlUx8C", "citedby": "0"}, {"bib": {"title": "The breast cancer specific K303R ER alpha mutation generates an integral site for AKT signaling", "year": "2004"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:BJbdYPG6LGMC", "citedby": "0"}, {"bib": {"title": "Breast cancer: Prognosis, Treatment and Prevention", "year": "2004"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:2VqYfGB8ITEC", "citedby": "0"}, {"bib": {"title": "Molecular Oncology, Markers, Clinical Correlates-Breast Cancer Patients with Progesterone Receptor PR-A-Rich Tumors Have Poorer Disease-Free Survival Rates.", "year": "2004"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:DUooU5lO8OsC", "citedby": "0"}, {"bib": {"title": "The MAPK inhibitor, DUSP6, is an estrogen receptor coactivator associated with tamoxifen resistance", "year": "2004"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:hCrLmN-GePgC", "citedby": "0"}, {"bib": {"title": "E13. Oestrogen receptors in metastatic breast cancer", "year": "2004"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:j8SEvjWlNXcC", "citedby": "0"}, {"bib": {"title": "Targeting the estrogen receptor in clinical", "year": "2003"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:edDO8Oi4QzsC", "citedby": "0"}, {"bib": {"title": "Estrogen receptor alpha haplotypes and breast cancer risk in older Caucasian women.", "year": "2002"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:jU7OWUQzBzMC", "citedby": "0"}, {"bib": {"title": "DCIS versus IBC: A cDNA microarray study", "year": "2002"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:rmuvC79q63oC", "citedby": "0"}, {"bib": {"title": "Breast Cancer: Prognosis, Treatment and Prevention", "year": "2002"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:ruyezt5ZtCIC", "citedby": "0"}, {"bib": {"title": "Genetic differences between non-invasive and invasive breast cancer by cDNA expression arrays", "year": "2002"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:XD-gHx7UXLsC", "citedby": "0"}, {"bib": {"title": "Hsp27 sensitizes breast cancer cells to paclitaxel.", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:YohjEiUPhakC", "citedby": "0"}, {"bib": {"title": "The Pyk2 kinase pathway is involved in hsp27-induced breast tumor invasiveness.", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:ML0RJ9NH7IQC", "citedby": "0"}, {"bib": {"title": "PMCID: PMC454161.", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:QyXJ3EUuO1IC", "citedby": "0"}, {"bib": {"title": "PROTEIN SYNTHESIS, POST-TRANSLATION MODIFICATION, AND DEGRADATION-Direct acetylation of the estrogen receptor a hinge region by p300 regulates transactivation and hormone \u2026", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:WC9gN4BGCRcC", "citedby": "0"}, {"bib": {"title": "An aqueous Chlorella extract inhibits IL-5 production by mast cells in vitro and reduces ovalbumin-induced eosinophil infiltration in the airway in mice in vivo.", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:L1USKYWJimsC", "citedby": "0"}, {"bib": {"title": "MECHANISMS OF SIGNAL TRANSDUCTION-Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor \u2026", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:umqufdRvDiIC", "citedby": "0"}, {"bib": {"title": "Heat shock protein 27 is involved in the turnover of c-Yes mRNA in human breast cancer cells leading to increased invasiveness", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:M7yex6snE4oC", "citedby": "0"}, {"bib": {"title": "Proceedings of the First International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer-Estrogen Receptor: Current Understanding of \u2026", "year": "2001"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:b1wdh0AR-JQC", "citedby": "0"}, {"bib": {"title": "Predicting Response to Adjuvant Therapy With Tamoxifen", "year": "2000"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:nrtMV_XWKgEC", "citedby": "0"}, {"bib": {"title": "4 Pathogenesis of Estrogen-Receptor-Positive and-Negative Breast Cancer", "year": "2000"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:SjuI4pbJlxcC", "citedby": "0"}, {"bib": {"title": "STEROID AND NUCLEAR RECEPTOR POLYMORPHISM VARIANTS IN HORMONE RESISTANCE AND HORMONE INDEPENDENCE", "year": "2000"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:kh2fBNsKQNwC", "citedby": "0"}, {"bib": {"title": "Immunohisto-chemical determination of P-glycoprotein in a rat mammary tumor treated with tamoxifen.", "year": "2000"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:OBSaB-F7qqsC", "citedby": "0"}, {"bib": {"title": "A constitutively active estrogen receptor (ER)-alpha increases PTHrP production and TGF beta-responsiveness by human breast cancer cells.", "year": "1999"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:yqoGN6RLRZoC", "citedby": "0"}, {"bib": {"title": "Fellowship to Identify New Mechanisms of Tamoxifen Resistance in Breast Cancer Patients", "year": "1999"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:r_AWSJRzSzQC", "citedby": "0"}, {"bib": {"title": "Estrogen receptor variants in early breast disease and breast cancer progression", "year": "1999"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:OR75R8vi5nAC", "citedby": "0"}, {"bib": {"title": "Tamoxifen-stimulated breast tumor growth correlates with oxidative stress and increased JNK activity", "year": "1999"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:kuK5TVdYjLIC", "citedby": "0"}, {"bib": {"title": "Adrian V Lee, Steffi Oesterreich, and Suzanne AW Fuqua", "year": "1998"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:WZBGuue-350C", "citedby": "0"}, {"bib": {"title": "Fellowship to Study the Involvement of Heat Shock Proteins in Drug Resistance in Human Breast Cancer.", "year": "1998"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:sNmaIFBj_lkC", "citedby": "0"}, {"bib": {"title": "Overexpression of HSP27 inhibits drug-induced apoptosis in breast cancer cells", "year": "1998"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:yFnVuubrUp4C", "citedby": "0"}, {"bib": {"title": "Tamoxifen-stimulated breast tumor growth is associated with cellular oxidative stress and increased JNK activity", "year": "1998"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:0N-VGjzr574C", "citedby": "0"}, {"bib": {"title": "Loss of heteroygosity at D14S62 is inversely correlated with metastatic potential", "year": "1998"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:Dip1O2bNi0gC", "citedby": "0"}, {"bib": {"title": "Tamoxifen stimulates estrogen receptor mediated transcription of the progesterone receptor", "year": "1998"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:e_rmSamDkqQC", "citedby": "0"}, {"bib": {"title": "The SPI transcription factor is involved in transcriptional regulation of the estrogen receptor gene in human breast cancer cells", "year": "1998"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:evX43VCCuoAC", "citedby": "0"}, {"bib": {"title": "Identification of FKHR as an estrogen receptor-interacting protein from tamoxifen-stimulated breast cancer", "year": "1998"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:2KloaMYe4IUC", "citedby": "0"}, {"bib": {"title": "A NOVEL NUCLEAR MATRIX PROTEIN REGULATES THE ACTIVITY OF THE PROMOTER OF THE SMALL HEAT SHOCK PROTEIN HSP27 IN BREAST CANCER CELLS.", "year": "1997"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:jE2MZjpN3IcC", "citedby": "0"}, {"bib": {"title": "Department of Oncology, University Hospital, S-22I HS Lund. Stveden fQ XI. ABj, and Department of Medicine/Medical Oncology, Unnrrsitv of Texas Health Science Center. San \u2026", "year": "1997"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:KbBQZpvPDL4C", "citedby": "0"}, {"bib": {"title": "The role of the estrogen receptor in breast cancer development and progression", "year": "1997"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:uc_IGeMz5qoC", "citedby": "0"}, {"bib": {"title": "DOUGLAS M. WOLF, CARL G. CASTLES, and D. CRAIG ALLRED", "year": "1996"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:-FonjvnnhkoC", "citedby": "0"}, {"bib": {"title": "PROGNOSTIC IMPLICATIONS OF HEAT SHOCK PROTEINS: 007\\406", "year": "1996"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:NyGDZy8z5eUC", "citedby": "0"}, {"bib": {"title": "Loss-of-heterozygosity on chromosome 14q is associated with invasive but non-metastatic breast cancer.", "year": "1996"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:WJVC3Jt7v1AC", "citedby": "0"}, {"bib": {"title": "A''hyperactive''estrogen receptor variant in hyperplastic breast lesions.", "year": "1996"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:NXb4pA-qfm4C", "citedby": "0"}, {"bib": {"title": "LOSS OF HETEROZYGOSITY ON CHROMOSOME-14 INVERSELY CORRELATED WITH METASTATIC POTENTIAL", "year": "1995"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:KUbvn5osdkgC", "citedby": "0"}, {"bib": {"title": "CLINICAL RELEVANCE OF ESTROGEN-RECEPTOR VARIANTS IN BREAST-CANCER (VOL 6, PG 77, 1995)", "year": "1995"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:EYYDruWGBe4C", "citedby": "0"}, {"bib": {"title": "Articles to appear in forthcoming issues of Cancer Treatment Reviews", "year": "1995"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:OcBU2YAGkTUC", "citedby": "0"}, {"bib": {"title": "CLONAL RELATIONSHIP BETWEEN PREMALIGNANT AND MALIGNANT BREAST DISEASE", "year": "1995"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:a9-T7VOCCH8C", "citedby": "0"}, {"bib": {"title": "Role for the estrogen receptor in breast cancer evolution", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:fEOibwPWpKIC", "citedby": "0"}, {"bib": {"title": "p53 Protein Accumulation Detected by Five Different Antibodies: Relationship to Prognosis and Heat Shock Protein 70 in Breast Cancer Richard M/Elledge", "year": "1994"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:VaXvl8Fpj5cC", "citedby": "0"}, {"bib": {"title": "16th annual San Antonio breast cancer symposium November 5-6, 1993", "year": "1993"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:XoXfffV-tXoC", "citedby": "0"}, {"bib": {"title": "Biological and clinical significances of heat shock protein hsp27 in breast cancer", "year": "1992"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:epqYDVWIO7EC", "citedby": "0"}, {"bib": {"title": "C-FGR ONCOGENE EXPRESSION IN HEMOPHILIA WITH ELEVATED EPSTEIN-BARR-VIRUS (EBV) SEROLOGY AND AIDS-LYMPHOMAS", "year": "1990"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:GtLg2Ama23sC", "citedby": "0"}, {"bib": {"title": "CHROMOSOMAL ASSIGNMENTS OF HUMAN 27-KDA HEAT-SHOCK PROTEIN (HSP27) RELATED SEQUENCES", "year": "1988"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:_5tno0g5mFcC", "citedby": "0"}, {"bib": {"title": "ESTROGEN-RECEPTOR GENE METHYLATION IN HUMAN-BREAST TUMORS", "year": "1988"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:S16KYo8Pm5AC", "citedby": "0"}, {"bib": {"title": "Monoclonal Antibody Studies of Drug Resistance", "year": "1987"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:mlAyqtXpCwEC", "citedby": "0"}, {"bib": {"title": "A RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM IN THE HUMAN ESTROGEN-RECEPTOR GENE IN PRIMARY HUMAN-BREAST CANCERS", "year": "1987"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:SpbeaW3--B0C", "citedby": "0"}, {"bib": {"title": "CLONING OF A CDNA FOR THE DRUG-RESISTANCE P-GLYCOPROTEIN AND EXPRESSION IN HUMAN-BREAST CANCER-CELLS", "year": "1986"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:HtEfBTGE9r8C", "citedby": "0"}, {"bib": {"title": "seminon in CELL BIOLOGY, Vo15, 1994: p I"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:PyEswDtIyv0C", "citedby": "0"}, {"bib": {"title": "Negative Regulation of Estrogen Receptor A Transactivation Functions by LIM Domain Only 4 Protein"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:rHJHxKgnXwkC", "citedby": "0"}, {"bib": {"title": "Prognosis and Heat Shock Protein 70 in Breast Cancer'"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:1lhNe0rCu4AC", "citedby": "0"}, {"bib": {"title": "Human Breast Cancer\u2019"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:ALROH1vI_8AC", "citedby": "0"}, {"bib": {"title": "An Estrogen Receptor Mutant with Strong Hormone-independent Activity from"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:CaZNVDsoPx4C", "citedby": "0"}, {"bib": {"title": "Estrogen Receptor Gene Methylation in Human Breast Tumors1"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:buQ7SEKw-1sC", "citedby": "0"}, {"bib": {"title": "Gene Expression Analysis In Red-R"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:FPJr55Dyh1AC", "citedby": "0"}, {"bib": {"title": "The 17th Annual SAN ANTONIO BREAST CANCER SYMPOSIUM"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:kz9GbA2Ns4gC", "citedby": "0"}, {"bib": {"title": "Ichigo S., 1 Ilesanmi AO, 31 Jacobs EC, 135 Jagannathan S., 83"}, "source": "citations", "id_citations": "Sw0mYdUAAAAJ:4MWp96NkSFoC", "citedby": "0"}]}